Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the...
-
WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development...
-
WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development...
-
WALTHAM, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immunology-based...
-
Financing led by SR One, NEA, Norwest Venture Partners, and Delos Capital with significant participation from Enavate Sciences, Longitude Capital, and other new and existing investors Proceeds to...
-
วอลแทม รัฐแมสซาชูเซตส์ วันที่, March 07, 2024 (GLOBE NEWSWIRE) -- ในวันนี้ Zenas...
-
WALTHAM, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- A Zenas BioPharma, uma empresa biofarmacêutica global comprometida em se tornar líder no desenvolvimento e comercialização de terapias voltadas...
-
월섬, 매사추세츠, March 07, 2024 (GLOBE NEWSWIRE) -- 염증 및 면역체계(I&I)에 기반한 치료법 개발과 상용화에 주력하는 글로벌 바이오 제약기업 제나스 바이오파마(Zenas BioPharma)가 Patricia Allen을 자사 이사회 임원으로 임명한다고 오늘 발표했다. Allen은 감사위원회 위원장도 겸직하게 된다....
-
マサチューセッツ州ウォルサム発, March 07, 2024 (GLOBE NEWSWIRE) --...
-
沃爾瑟姆，馬薩諸塞州, March 07, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma 是一家全球生物製藥公司，致力於成為炎症與免疫定向療法開發和商業化的領導者，今日宣布任命 Patricia Allen 為董事會成員，同時她還將擔任審計委員會主席。加入 Zenas 董事會時，Allen...